Depression, cytokines, and glial function (Q24170129)

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

Mind glue: implications of glial cell biology for psychiatry

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

Galen -- on mental disorders

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

Glial control of synaptic function.

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

Major depression and activation of the inflammatory response system

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

Evidence for an immune response in major depression: a review and hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

The macrophage theory of depression

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

Cytokines and psychopathology: lessons from interferon-alpha

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

Hippocampal volume, memory, and cortisol status in major depressive disorder: effects of treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

Is impaired neurogenesis relevant to the affective symptoms of depression?

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

Genetics and genomics of depression

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

Glucocorticoids, depression, and mood disorders: structural remodeling in the brain

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illness

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

Glial fibrillary acidic protein immunoreactivity in the prefrontal cortex distinguishes younger from older adults in major depressive disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

Vagus nerve stimulation (VNS) for major depressive episodes: one year outcomes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

Enlargement of the amygdala in patients with a first episode of major depression

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

Low glial numbers in the amygdala in major depressive disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

Neuroimaging studies of mood disorder effects on the brain

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

Oligodendrocyte dysfunction in schizophrenia and bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

Assessing antidepressant activity in rodents: recent developments and future needs

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

Chemically induced neuronal damage and gliosis: enhanced expression of the proinflammatory chemokine, monocyte chemoattractant protein (MCP)-1, without a corresponding increase in proinflammatory cytokines(1).

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

Glial cell abnormalities in major psychiatric disorders: the evidence and implications

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

A quantitative immunohistochemical study of astrocytes in the entorhinal cortex in schizophrenia, bipolar disorder and major depression: absence of significant astrocytosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders. A review and a Western blot study of synaptophysin, GAP-43 and the complexins

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

Questions raised by the cytokine hypothesis of depression

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

Treatment of cytokine-induced depression

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

Effects of antidepressants on cytokine production and actions.

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

Experimental autoimmune encephalomyelitis-associated behavioral syndrome as a model of 'depression due to multiple sclerosis'.

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

Cytokine-induced sickness behavior.

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

Cytokines and depression: the need for a new paradigm

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

Cytokines and sickness behavior: implications for cancer care and control

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

Antidepressants and neuroplasticity

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

Truncated TrkB-T1 mediates neurotrophin-evoked calcium signalling in glia cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

Age-dependent reductions in the level of glial fibrillary acidic protein in the prefrontal cortex in major depression

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

Hippocampal atrophy in recurrent major depression

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

Glial reduction in the subgenual prefrontal cortex in mood disorders

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

Induction of gp130-related Cytokines and Activation of JAK2/STAT3 Pathway in Astrocytes Precedes Up-regulation of Glial Fibrillary Acidic Protein in the 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Model of Neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

Cytokines, stress and depressive illness: brain‐immune interactions

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

Plasma fatty acid composition and depression are associated in the elderly: the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

Amygdala core nuclei volumes are decreased in recurrent major depression

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

Cytokine hypothesis of overtraining: a physiological adaptation to excessive stress?

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

Raised plasma levels of tumor necrosis factor alpha in patients with depression: normalization during electroconvulsive therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

Cytokines and the brain: implications for clinical psychiatry

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

Genetic risk, number of previous depressive episodes, and stressful life events in predicting onset of major depression

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

Unmasking disease-specific cerebral blood flow abnormalities: mood challenge in patients with remitted unipolar depression

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

The functional neuroanatomy of the placebo effect

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

Untreated Depression and Hippocampal Volume Loss

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

Reducing the global burden of depression

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021

Reactive astrocytes protect tissue and preserve function after spinal cord injury

1 reference

https://api.crossref.org/works/10.1016%2FJ.METABOL.2005.01.011

7 January 2021